Concepedia

Mark Shelly

MS

15

Publications

850

Citations

12

H-Index

1995

Active since

Affiliations

University of Rochester Medical Center(Current)

University of Rochester

Highland Hospital

Hebrew University of Jerusalem

Mark Shelly is an author at University of Rochester Medical Center specializing in medicine, immunology, and infection control.

ORCID

Top concepts

Publications per year

1995–2025

15

Publications

15

A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome

James A. Sloand, Mark Shelly, Andrew Feigin et al. · American Journal of Kidney Diseases · 2004 · 206 citations

, , +2

Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C

In H. Park, Matthew R. Moore, John J. Treanor et al. · The Journal of Infectious Diseases · 2008 · 154 citations · Full text

Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults

Mark Shelly, Helen Jacoby, Gregory J. Riley et al. · Infection and Immunity · 1997 · 120 citations · Full text

, , +12

Normalization of Lithium-Induced Hypercalcemia and Hyperparathyroidism With Cinacalcet Hydrochloride

James A. Sloand, Mark Shelly · American Journal of Kidney Diseases · 2006 · 62 citations

, , +6

Cache Valley Virus in a Patient Diagnosed with Aseptic Meningitis

Nang L. Nguyen, Guoyan Zhao, Rene Hull et al. · Journal of Clinical Microbiology · 2013 · 58 citations · Full text

Rows per page

1–5 of 15